This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Forschungsverbund Berlin E.v.. Active years: 2011-2015.
Company Filing History:
Years Active: 2011-2015
Title: Enno Klussmann: Innovator in Cardiovascular Treatment and Protein Kinase Research
Introduction
Enno Klussmann is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of medical research, particularly in the treatment of cardiovascular diseases and protein kinase A anchor proteins. With a total of 2 patents, Klussmann's work is recognized for its innovative approach to addressing critical health issues.
Latest Patents
Klussmann's latest patents include two groundbreaking inventions. The first patent focuses on N-arylaminomethylene benzothiophenones for the treatment of cardiovascular disease. This invention relates to compounds that can be used as drugs to treat cardiovascular conditions, specifically detailing the chemical structure and potential applications of these compounds. The second patent involves nucleic acid molecules encoding AKAP18 delta, a splice variant of a protein kinase A anchor protein. This invention encompasses polynucleotides that encode AKAP proteins and outlines methods for determining their interactions with regulatory subunits of protein kinase A.
Career Highlights
Enno Klussmann is affiliated with Forschungsverbund Berlin E.V., where he conducts his research and development activities. His work has been instrumental in advancing the understanding of cardiovascular treatments and protein interactions, contributing to the broader field of medical science.
Collaborations
Klussmann has collaborated with notable colleagues, including Walter Rosenthal and Alexander Oksche. These partnerships have fostered a collaborative environment that enhances the research output and innovation in their respective fields.
Conclusion
Enno Klussmann stands out as an influential inventor whose work in cardiovascular treatment and protein kinase research has the potential to make a significant impact on medical science. His patents reflect a commitment to innovation and the advancement of healthcare solutions.